Skip to main content
Premium Trial:

Request an Annual Quote

ABI, Institute for Systems Biology Pen Proteomics Collaboration

NEW YORK, Aug. 27 - Applied Biosystems and the Institute for Systems Biology today said they will collaborate to develop new proteomic technologies and applications.

 

The partners said they will use mass spectrometry, chemical tagging, and bioinformatics, including LC MALDI workflows, to devise better ways to analyze proteins in various biological pathways.

 

Meantime, ISB will use ABI's 4700 proteomics analyzer with ToF/ToF optics and the ICAT reagent technology to help it study human immunity.

 

ISB researchers in Seattle and teams from ABI's proteomics research center in Framingham, Mass., will perform the research.

 

Click here for more information.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.